Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-061408
Filing Date
2013-11-14
Accepted
2013-11-14 10:02:46
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v359054_10q.htm 10-Q 479096
2 EXHIBIT 31.1 v359054_ex31-1.htm EX-31.1 9977
3 EXHIBIT 31.2 v359054_ex31-2.htm EX-31.2 9961
4 EXHIBIT 32.1 v359054_ex32-1.htm EX-32.1 8265
5 EXHIBIT 32.2 v359054_ex32-2.htm EX-32.2 8122
  Complete submission text file 0001144204-13-061408.txt   2259983

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enmd-20130930.xml EX-101.INS 207197
7 XBRL TAXONOMY EXTENSION SCHEMA enmd-20130930.xsd EX-101.SCH 22866
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enmd-20130930_cal.xml EX-101.CAL 22065
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enmd-20130930_def.xml EX-101.DEF 119254
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enmd-20130930_lab.xml EX-101.LAB 176429
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enmd-20130930_pre.xml EX-101.PRE 138149
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
ENTREMED INC (Filer) CIK: 0000895051 (see all company filings)

EIN.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-20713 | Film No.: 131217266
SIC: 2836 Biological Products, (No Diagnostic Substances)